Cargando...

Cost-effectiveness of edoxaban compared to warfarin for the treatment and secondary prevention of venous thromboembolism in the UK

Background: Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is the third most common acute cardiovascular disease and represents an important burden for patients and payers. Objective: The aim was to estimate the cost-effectiveness of edoxaban, a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Mark Access Health Policy
Main Authors: Clay, Emilie, Jamotte, Aurélien, Verhamme, Peter, Cohen, Alexander T., Van Hout, Ben. A., Gumbs, Pearl.
Formato: Artigo
Idioma:Inglês
Publicado: Routledge 2018
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6052426/
https://ncbi.nlm.nih.gov/pubmed/30034645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/20016689.2018.1495974
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!